Watts Ryan J. bought DNLI
January 3, 2026 · Form 4 insider transaction
Watts Ryan J. bought 236,880 shares of Denali Therapeutics Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
236,880
Price
$0.00
Total value
N/A
InsiderWatts Ryan J.
Role—
SecurityStock Option (right to buy)
Transaction codeA: Grant or award
Transaction dateJanuary 3, 2026
Filing dateJanuary 5, 2026
Shares owned after236,880
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
25% of the shares subject to the option shall vest on January 3, 2027, and 1/48 of the shares subject to the option shall vest each month thereafter, subject to the Reporting Person remaining a service provider of the Issuer through each such date